Abstract
Cyclic adenosine monophosphate (cAMP) regulates long-term potentiation (LTP) and ameliorates memory in healthy and diseased brain. Increasing evidence shows that, under physiological conditions, low concentrations of amyloid β (Aβ) are necessary for LTP expression and memory formation. Here, we report that cAMP controls amyloid precursor protein (APP) translation and Aβ levels, and that the modulatory effects of cAMP on LTP occur through the stimulation of APP synthesis and Aβ production.
© 2014 American Neurological Association.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amyloid beta-Peptides / metabolism*
-
Amyloid beta-Protein Precursor / deficiency
-
Amyloid beta-Protein Precursor / genetics
-
Animals
-
Cells, Cultured
-
Colforsin / pharmacology
-
Cyclic AMP / metabolism
-
Cyclic AMP / pharmacology*
-
Cyclic AMP-Dependent Protein Kinases / genetics
-
Cyclic AMP-Dependent Protein Kinases / metabolism
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation / drug effects
-
Hippocampus / cytology
-
Humans
-
In Vitro Techniques
-
Long-Term Potentiation / drug effects
-
Long-Term Potentiation / genetics
-
Male
-
Memory / physiology*
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neurons / drug effects*
-
Neurons / metabolism
-
Rats
-
Rats, Sprague-Dawley
Substances
-
Amyloid beta-Peptides
-
Amyloid beta-Protein Precursor
-
Enzyme Inhibitors
-
Colforsin
-
Cyclic AMP
-
Cyclic AMP-Dependent Protein Kinases